NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Life Sciences



Studies from IVAX Drug Research Institute Ltd. yield new information about life sciences



May 16th, 2008

Fresh data on life sciences are presented in the report 'Determination of estredox, a compound with sustained estradiol function, and its impurity profile by HPLC.' According to recent research published in the journal Pharmazie, "The HPLC methods described here for the assay and purity test of Estredox (E2CDS), a molecule with a redox-based, brain-targeted chemical delivery system for estradiol, allow reliable conclusions to be made on the potency and purity of API and E2CDS/HPCD complex samples. Extensive work was done to isolate and characterize the major, potential contaminants, and ensure the required stability of solutions of E2CDS, an inherently labile compound by...


Source: Health Business Week (2008-05-16)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login